<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - SPNC</title>
<description>International Business News - SPNC</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Ahead of the Bell: Spectranetics upgraded</title>
  <description>A Goldman Sachs analyst upgraded Spectranetics Corp. Tuesday, saying the stock will trade around its current price until more details emerge about government investigations into the medical device maker.</description>
    <link>http://www.ibtimes.com/articles/20080930/ahead-of-the-bell-spectranetics-upgraded.htm</link> 
  <pubDate>Tue, 30 Sep 2008 08:52:26 EDT</pubDate>
  </item>


  <item>
  <title>Spectranetics faces lawsuits, SEC request</title>
  <description>Medical device maker Spectranetics Corp. said Thursday it faces several lawsuits and a Securities and Exchange Commission request for documents as an investigation into its operations continues.</description>
    <link>http://www.ibtimes.com/articles/20080925/spectranetics-faces-lawsuits-sec-request.htm</link> 
  <pubDate>Thu, 25 Sep 2008 07:56:12 EDT</pubDate>
  </item>


  <item>
  <title>Enrollment halted in trial of lasers with stents</title>
  <description>A physicians group running a study of the use of Spectranetics Corp.'s lasers with nitinol stents has voluntarily stopped enrollment in the study to address safety concerns, the company said Monday.</description>
    <link>http://www.ibtimes.com/articles/20080915/spectranetics-halts-enrollment-on-safety-concerns.htm</link> 
  <pubDate>Mon, 15 Sep 2008 19:40:13 EDT</pubDate>
  </item>


  <item>
  <title>Ahead of the Bell: Spectranetics</title>
  <description>Wall Street is still looking for details on a federal investigation into Spectranetics Corp., but the medical device maker's stock rebounded in premarket trading Friday following a plunge the day before.</description>
    <link>http://www.ibtimes.com/articles/20080905/ahead-of-the-bell-spectranetics.htm</link> 
  <pubDate>Fri, 05 Sep 2008 09:28:20 EDT</pubDate>
  </item>


  <item>
  <title>FDA, ICE serve warrant on Spectranetics Corp.</title>
  <description>Medical device maker Spectranetics Corp. said federal officials served it with a search warrant Thursday. Its shares were down $4.27, or 47 percent, at $4.73 when Nasdaq halted their trading pending the news announcement Thursday afternoon. The company said that trading would resume Friday.</description>
    <link>http://www.ibtimes.com/articles/20080904/fda-ice-serve-warrant-on-spectranetics-corp.htm</link> 
  <pubDate>Thu, 04 Sep 2008 22:42:34 EDT</pubDate>
  </item>


  <item>
  <title>Spectranetics changes leadership of vascular unit</title>
  <description>Medical device maker Spectranetics Corp. on Wednesday announced a series of moves that reduce the number of executives in its heart surgery business. Spectranetics promoted Jennifer Vaughn to vice president of U.S. sales in the vascular intervention unit, replacing Steve Okland, who is leaving the company. Spectranetics also said it has eliminated the two sales director positions in the vascular intervention business, which will allow Vaughn to work more directly with regional managers.</description>
    <link>http://www.ibtimes.com/articles/20080813/spectranetics-changes-leadership-of-vascular-unit.htm</link> 
  <pubDate>Wed, 13 Aug 2008 12:34:18 EDT</pubDate>
  </item>


  <item>
  <title>Spectranetics reaffirms 2008 revenue outlook</title>
  <description>Medical device maker Spectranetics Corp. on Tuesday reaffirmed its outlook for full-year revenue within range of Wall Street estimates. The company expects revenue between $104 million and $110 million. Analysts polled by Thomson Financial expect revenue of $105.6 million.</description>
    <link>http://www.ibtimes.com/articles/20080729/spectranetics-reaffirms-2008-revenue-outlook.htm</link> 
  <pubDate>Tue, 29 Jul 2008 10:25:52 EDT</pubDate>
  </item>


  <item>
  <title>Spectranetics posts 2nd-quarter loss; shares fall</title>
  <description>Medical device maker Spectranetics Corp. on Tuesday reported a second-quarter loss on higher costs for acquired products. For the quarter ended June. 30, the company lost $2.6 million, or 8 cents per share, compared with a profit of $7.2 million, or 21 cents per share, during the same period a year prior. Revenue rose 31 percent to $26.7 million from $20.4 million.</description>
    <link>http://www.ibtimes.com/articles/20080729/spectranetics-posts-2nd-quarter-loss-shares-fall.htm</link> 
  <pubDate>Tue, 29 Jul 2008 10:22:05 EDT</pubDate>
  </item>


  <item>
  <title>Sector Snap: Medical technology</title>
  <description>Medical technology stocks gained ground Wednesday after a Citi Investment Research analyst said opportunities remain in a challenging sector as he sifted through the companies ahead of their quarterly results.</description>
    <link>http://www.ibtimes.com/articles/20080709/sector-snap-medical-technology.htm</link> 
  <pubDate>Wed, 09 Jul 2008 15:13:06 EDT</pubDate>
  </item>


  <item>
  <title>Spectranetics, Medtronic settle intellectual property suit</title>
  <description>Spectranetics Corp. said Monday it has settled its intellectual property dispute with Medtronic, with Medtronic licensing the patent at issue. Terms of the settlement agreement were not disclosed.</description>
    <link>http://www.ibtimes.com/articles/20080428/spectranetics-medtronic-settle-intellectual-property-suit.htm</link> 
  <pubDate>Mon, 28 Apr 2008 08:41:37 EDT</pubDate>
  </item>


</channel>
</rss>